IDP Insider Trading Activity and SEC Form 4 Filings
IDP insider trading summary
No open-market insider purchases or sales of Idera Pharmaceuticals, Inc. (IDP) have been reported on SEC Form 4 in the past 12 months.
Latest IDP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 29, 2008 | Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Sell | $294K (19,670 @ $14.93) |
| Jul 29, 2008 | Baker Bros. Capital (GP), LLC | 10% Owner | Sell | $28K (1,885 @ $14.93) |
| Jul 29, 2008 | Felix Baker | 10% Owner | Sell | $294K (19,670 @ $14.93) |
| Jul 29, 2008 | Baker Biotech Capital (GP), LLC | 10% Owner | Sell | $147K (9,839 @ $14.93) |
| Jul 29, 2008 | Julian Baker | 10% Owner | Sell | $294K (19,670 @ $14.93) |
| Jul 29, 2008 | 14159 capital (GP), LLC | 10% Owner | Sell | $9K (606 @ $14.93) |
| Jul 29, 2008 | Julian Baker | 10% Owner | Sell | $28K (1,885 @ $14.93) |
| Jul 29, 2008 | Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Sell | $294K (19,670 @ $14.93) |
| Jul 29, 2008 | Julian Baker | 10% Owner | Sell | $9K (606 @ $14.93) |
| Jul 29, 2008 | Felix Baker | 10% Owner | Sell | $28K (1,885 @ $14.93) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.